Clinical Trials Logo

Filter by:
NCT ID: NCT05496166 Not yet recruiting - Clinical trials for Limited Stage Small Cell Lung Cancer

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Start date: August 1, 2023
Phase: Phase 3
Study type: Interventional

To compare the efficiency between surgery and radiotherapy after SHR-1316 (Adebrelimab)and platinum-containing doublet induction therapy for limited-stage small cell lung cancer

NCT ID: NCT05541744 Not yet recruiting - Lung Cancer Clinical Trials

The Use of Molecular Radiogenomics in Non-small Cell Lung Cancer

NSCLC
Start date: August 1, 2023
Phase:
Study type: Observational

Lung cancer is currently the leading cause of cancer-related mortality worldwide, and the dominant histopathology is non-small cell lung cancer (NSCLC). Although many new targeted and immunomodulation therapies have emerged, not all patients are responsive to novel therapeutics. A more reliable and accurate risk stratification model to predict the treatment response and survival outcomes are still lacking. The 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) derived radiomics can be used to interrogate tumor biologies such as glycolytic activity and heterogeneity. It can, therefore, be used to predict treatment response and survival outcomes. Cancer genomics derived from gene sequencing can evaluate cancer's genetic alterations. It can be used to feature the genotype of the tumor. However, both tools have drawbacks; combining these two modalities may enable a more robust predictive model for more precise clinical decisions. During the investigator's former study project, the investigators published four Science Citation Index journal papers using the investigators' research results, which found that 18F-FDG PET radiomics can independently predict regional lymph node metastasis in NSCLC and cancer survival by stage. The preliminary findings of the investigator's former research project also disclosed an association between 18F-FDG PET-derived molecular radiomics with genomic heterogeneity and mutation of specific glucose metabolic genes. This time, the investigators plan to include deep radiomics in addition to traditional handcrafted radiomics. The investigators aim to investigate the radiogenomic patterns in different driver gene mutation statuses and clinical scenarios. Finally, the investigators seek to use radiogenomics as a prognostic stratification tool in patients with NSCLC.

NCT ID: NCT05647174 Not yet recruiting - Airway Management Clinical Trials

MGPOCUS Assisted Bronchoscopy in Difficult Endotracheal Intubation

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Introduction Endoracheal intubation (ETI) is a crucial but risky procedure, especially among patients with suspected difficult endotracheal intubation (DTI). Bronchoscopy, as an improved technique commonly used in DTI, might encounters the difficulties of visualization. The magnetic point-of-care ultrasound (MGPOCUS) not only provide an novel visualization from outside, but also enable the estimation of relative position and trajectory of bronchoscopy. The study aims to evaluate the efficiency of MGPOCUS assisted bronchoscopy in time taken to the first-attempt success, the first-attempt and overall success of ETI, complications and satisfaction of visualization among patients suspected with DTI. Methods and analysis The current study is a randomized, parallel-group, single-blinded, single-center study. Participants (n=350) will be recruited by primary anesthesiologist and randomized to groups of ETI with bronchoscopy or MGPOCUS assisted bronchoscopy. The primary outcome is time taken to the first-attempt success ETI. Secondary outcomes include procedure time, the first-attempt and overall success, complications and satisfaction of visualization. Cox regression with the Bonferroni correction and the linear mixed regression will be used to analysis the outcomes.

NCT ID: NCT05669079 Not yet recruiting - Poor Graft Function Clinical Trials

Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT

Start date: August 1, 2023
Phase: Phase 3
Study type: Interventional

This randomized trial aimed at validating the efficacy and safety of low-dose decitabine, together with umbilical cord blood in PGF post allo-HSCT patients.

NCT ID: NCT05669261 Not yet recruiting - Long COVID Clinical Trials

Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional

The project is described as a Phase 1 Clinical Safety Study intended to provide preliminary assessments of the safety, tolerability, and secondarily to be vigilant for signals of amelioration of symptoms associated with Post-Acute Sequelae of SARS-CoV-2 infection

NCT ID: NCT05672966 Not yet recruiting - Clinical trials for Human Papillomavirus Infection

Phase I Clinical Trial of a Candidate HPV Vaccine

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional

This is a Phase I, first-in-human, randomized, observer-blinded, placebo-controlled, dose escalation study to evaluate the safety, tolerability, and immunogenicity of BV601 (a HPV Vaccine) in healthy adult volunteers.

NCT ID: NCT05678205 Not yet recruiting - Breast Cancer Clinical Trials

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

Start date: August 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This clinical trial will enroll subjects with HER2+ solid tumors and is conducted in two phases. The primary objective of Phase 1 is to determine the safety and tolerability of AB-201 in subjects with advanced HER2+ solid tumors. The primary objective of Phase 2 is to evaluate the efficacy of AB-201. Subjects will receive up to 3 doses of AB-201, followed by scheduled assessments of overall health and tumor response.

NCT ID: NCT05718037 Not yet recruiting - Herpes Zoster Clinical Trials

Phase I Clinical Trial of a Candidate Herpes Zoster Vaccine

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional

This is a phase I, randomized, observer-blinded study to evaluate the safety, tolerability, and immunogenicity of BV211(a herpes zoster vaccine) in Adult Volunteers.

NCT ID: NCT05721196 Not yet recruiting - Bipolar Disorder Clinical Trials

Culturally Adapted Psychoeducation (CaPE) for Bipolar Disorders in Nigeria

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

Bipolar disorders are chronic mental health disorders that often result in functional impairment, constituting a significant disease burden. It also accounts for seven per cent of disability-adjusted life years caused by mental disorders. Four out of ten persons with a probable diagnosis of bipolar disorders received no mental health care within the preceding twelve months. Compared to the general population, individuals with bipolar disorders tend to have a significantly higher rate of associated suicide mortality. Within the last decade, these mortality rates have substantially increased, suggesting the need for targeted research to address the unresolved needs of individuals suffering from bipolar disorders. A recent meta-analysis found that compared to the general population, bipolar patients had reduced life expectancy with about thirteen years of potential life loss. Bipolar disorders are historically under-researched compared to other mental health disorders, especially in Sub-Saharan Africa and Nigeria. Our recent study on bipolar disorders in Nigeria provided insight into contextual knowledge and beliefs about bipolar disorders, including the lived experiences of patients with bipolar disorders, their caregivers, and clinicians in Nigeria. The study recommended culturally adapted psychosocial intervention for bipolar patients, hence the proposed research.

NCT ID: NCT05728385 Not yet recruiting - Asthma in Children Clinical Trials

Impact of Modified Specific Carbohydrate Diet on Bronchial Asthma Control in Children

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The aim of this study will explore if the specific carbohydrate diet has an effect on asthma control in children and if it will affect the frequency, severity, and duration of asthma and thus provide it as a potential complementary treatment option for them.